[N:1]1([CH:6]([C:10]2[CH:19]=[C:18]3[C:13]([NH:14][C:15](=[O:25])[C:16]([C:20]([O:22]CC)=[O:21])=[N:17]3)=[CH:12][CH:11]=2)[CH:7]([CH3:9])[CH3:8])[CH:5]=[CH:4][N:3]=[CH:2]1.[OH-].[Na+].S(=O)(=O)(O)O>>[N:1]1([CH:6]([C:10]2[CH:19]=[C:18]3[C:13]([NH:14][C:15](=[O:25])[C:16]([C:20]([OH:22])=[O:21])=[N:17]3)=[CH:12][CH:11]=2)[CH:7]([CH3:8])[CH3:9])[CH:5]=[CH:4][N:3]=[CH:2]1A solution of 4.25 parts of ethyl 3,4-dihydro-7-[1-(1H-imidazol-1-yl)-2-methylpropyl]3-oxo-2-quinoxalinecarboxylate in 20 parts of a sodium hydroxide solution 1N was stirred for 4 hours at room temperature. The reaction mixture was treated with a diluted sulfuric acid solution to pH 5.5. After concentration, the residue was crystallized from pyridine. The product was filtered off and dried, yielding 1 part (24.6%) of 3,4-dihydro-7-[1-(1H-imidazol-1-yl)-2-methylpropyl]-3-oxo-2-quinoxalinecarboxylic acid; mp. 237.5° C. (comp. 129).